Innocan Pharma Celebrates Dr. Joseph Pergolizzi's Achievement
Innocan Pharma Corporation has recently acknowledged Dr. Joseph V. Pergolizzi, Jr. for being recognized as one of the top 2% most-cited scientists in the world according to a new list from Stanford University. This remarkable achievement highlights Dr. Pergolizzi's significant contributions to medical science and emphasizes his influential role in advancing healthcare practices globally.
Dr. Pergolizzi's Role at Innocan Pharma
Appointed to Innocan Pharma's Scientific Advisory Board, Dr. Pergolizzi focuses on enhancing drug development and supporting the company’s initiatives for FDA filing on new medications. His extensive experience in pain management and critical care medicine is invaluable as Innocan navigates the complexities of pharmaceutical advancements.
CEO's Praise for Dr. Pergolizzi
Iris Bincovich, CEO of Innocan Pharma, expressed immense pride in Dr. Pergolizzi's recognition. She emphasized his influential work in medical research, which has significantly contributed to Innocan's research and development goals. Dr. Pergolizzi’s expertise has been crucial in aligning the company's strategies with FDA regulatory standards, facilitating innovative therapies aimed at improving patients' quality of life.
Innovative Segments of Innocan Pharma
Innocan Pharma operates through two key segments, Pharmaceuticals and Consumer Wellness. The Pharmaceuticals branch is dedicated to creating advanced drug delivery platforms utilizing cannabinoids to treat diverse medical conditions, enhancing the overall well-being of patients.
Pharmaceuticals Segment Focus
The pharmaceuticals segment features innovative technologies, including the LPT CBD-loaded liposome platform. This platform provides precise dosing and regulates the release of CBD into the bloodstream, with ongoing preclinical trials for epilepsy and pain management.
Consumer Wellness Initiatives
Innocan’s Consumer Wellness segment is dedicated to producing high-performance self-care products that promote healthier lifestyles. The company has also formed a joint venture named BI Sky Global Ltd. to enhance targeted online sales, further solidifying its market presence.
Contacting Innocan Pharma
For information regarding Innocan Pharma Corporation, interested parties can reach out to:
Iris Bincovich, CEO
+1 5162104025
+972-54-3012842
+442037699377
Email: info@innocanpharma.com
Frequently Asked Questions
What recognition did Dr. Joseph Pergolizzi receive?
Dr. Pergolizzi was recognized among the top 2% most-cited scientists worldwide by Stanford University.
What is the main focus of Innocan Pharma?
Innocan Pharma focuses on developing innovative drug delivery platforms and self-care wellness products.
How does Dr. Pergolizzi contribute to Innocan Pharma?
He contributes by guiding the company’s pharmaceutical R&D and assisting with FDA submissions.
What are Innocan's key segments?
The key segments of Innocan are Pharmaceuticals and Consumer Wellness, targeting innovative therapies and wellness products.
How can people contact Innocan Pharma?
People can contact Innocan Pharma via email or phone as provided in the contact information section.